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Abstract
Background: DYT1 dystonia, a severe form of genetically determined human dystonia, exhibits reduced penetrance among
carriers and begins usually during adolescence. The reasons for such age dependence and variability remain unclear.
Methods and Results: We characterized the alterations in D2 dopamine receptor (D2R) signalling in striatal cholinergic
interneurons at different ages in mice overexpressing human mutant torsinA (hMT). An abnormal excitatory response to the
D2R agonist quinpirole was recorded at postnatal day 14, consisting of a membrane depolarization coupled to an increase
in spiking frequency, and persisted unchanged at 3 and 9 months in hMT mice, compared to mice expressing wild-type
human torsinA and non-transgenic mice. This response was blocked by the D2R antagonist sulpiride and depended upon G-
proteins, as it was prevented by intrapipette GDP-b-S. Patch-clamp recordings from dissociated interneurons revealed a
significant increase in the Cav2.2-mediated current fraction at all ages examined. Consistently, chelation of intracellular
calcium abolished the paradoxical response to quinpirole. Finally, no gross morphological changes were observed during
development.
Conclusions: These results suggest that an imbalanced striatal dopaminergic/cholinergic signaling occurs early in DYT1
dystonia and persists along development, representing a susceptibility factor for symptom generation.
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Introduction
DYT1 dystonia is a common form of inherited, generalized
dystonia, with onset in childhood or adolescence, characterized by
sustained muscle contractions causing twisting, repetitive move-
ments and progressive abnormal postures [1]. It is produced by a
single pathogenic codon deletion in the C-terminal of the protein
torsinA, a member of AAA+ (‘‘ATPases associated with a variety
of cellular activities’’) protein family of chaperone-like proteins,
involved in protein trafficking, membrane fusion and participating
in secretory processing [2–4]. Although at system level the precise
consequences of torsinA mutation are still unclear, imbalances in
neurotransmission in basal ganglia circuits as well as in the
sensorimotor cortex and cerebellum have been documented [5–7].
Experimental and clinical evidence point to the striatum, where
dopamine (DA) and acetylcholine (ACh) interact, as one of the
principal sites of network dysfunction in DYT1 dystonia [8–11].
Although small in number, cholinergic interneurons are the sole
source of striatal ACh, playing an essential role both in striatal
synaptic plasticity and motor learning, as well as in the
pathophysiology of movement disorders, such as Parkinson’s
disease (PD) and dystonia [12–15]. Of note, cholinergic interneu-
rons are exclusively found in regions with a dense dopaminergic
innervation, such as the dorsal striatum. In these regions,
dopaminergic afferents exert a powerful control over cholinergic
transmission. Maintenance of ACh levels is indeed regulated by
ACh degrading enzymes, by muscarinic M2/M4 autoreceptors
[14,16] but also by an inhibitory DA D2 receptor (D2R) action
[17–19]. Our previous studies identified a fundamental alteration
in the balance between striatal DA and ACh. Normally, activation
of D2Rs reduces the activity of cholinergic interneurons, whereas
in interneurons from transgenic mice overexpressing human
mutant torsinA (hMT), D2R activation dramatically increases,
rather than decrease, the spike rate [20].
Because DYT1 dystonia is considered a neurodevelopmental
disorder [2,7,9], in the present work we characterized the receptor
and post-receptor mechanisms involved in this abnormal response,
extending this analysis to different developmental stages. Similarly,
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determined in the three strains of mice. Since strong level of
torsinA mRNA is observed in cholinergic interneurons from both
human and rodent striatum [21–23] a morphological analysis of
cholinergic interneurons was performed at different ages. Our
results demonstrate that torsinA mutation alters striatal function
early in development. An imbalanced interplay between striatal
DA and ACh distorts network function, and might predispose gene
mutation carriers to develop dystonia, but these data also suggest
that additional factors are required to trigger the appearance of
clinical symptoms.
Methods
Transgenic animals and tissue preparation
Treatment and handling of mice were carried out in
accordance with both the EC and Italian guidelines (86/609/
EEC; D.Lvo 116/1992), approved by the Animal Ethics
Committee of the University of Rome ‘‘Tor Vergata’’ (n. 153/
2001A) and by the Santa Lucia Foundation Animal Care and
Use committee (Authorization n 9/2006-A; protocol n. 14/2008
and n. 07/2011). All the efforts were made to minimize the
number of animals utilized and their suffering. Transgenic mice
were generated as previously described [24] and bred at our
animal house. Non-transgenic (NT) littermates were utilized as
controls. DNA extracted from mouse tail using the Extract-N-
Amp Tissue PCR Kit (Catalog Numbers XNAT2, Sigma-
Aldrich, Italy) was used for genotyping as described previously
[6]. To amplify a 560 bp segment, two specific primers for
human torsinA were utilised (59-CACATTGCACTTTCCA-
CATGCT -39 and 59-GTTTTGCAGCCTTTATCTGA-39),
and prepared according to the ‘‘Tissue Preparation’’ and
‘‘Reagent Preparation’’ protocols (Sigma-Aldrich; 35 cycles;
annealing temperature 60uC). The human torsinA coding
sequence was identified via 1.5% agarose gel electrophoresis.
The mouse genotype was confirmed by restriction digestion with
BseRI (New England BioLabs, USA). The human torsinA and
human mutant torsinA PCR products were digested with BseRI
into different fragments (279 bp, 238 bp, 24 bp, 22 bp and
279 bp, 259 bp, and 22 bp, respectively). Then, fragment profiles
were identified by gel electrophoresis, using 2% SYBR Safe
agarose (Invitrogen, Italy). Mice displayed comparable increases
of torsinA protein in the striatum compared to their non-
transgenic littermates [11].
Striatal slices. Mice were sacrificed by cervical dislocation
under ether anaesthesia and the brain immediately removed from
the skull. Coronal corticostriatal slices (250–300 mm) were cut with
a vibratome in Krebs’ solution (in mM: 126 NaCl, 2.5 KCl, 1.3
MgCl2, 1.2 NaH2PO4, 2.4 CaCl2, 10 glucose, 18 NaHCO3),
bubbled with 95% O2/and 5% CO2. After 1 h recovery, a single
slice was transferred into a recording chamber (,0,5–1 ml
volume), continuously superfused with oxygenated Krebs’
medium, at 2.5–3 ml/min and maintained constantly at 32–
33uC [6]. A single slice was used for pharmacological experiments.
Electrophysiology
Cholinergic interneurons were visualized on a monitor (Sony)
using a differential interference contrast (DIC, Nomarski) optical
system combined with an infrared (IR) filter, and a monochrome
CCD camera (C3077, Hamamatsu). Recordings were made with
Multiclamp 700b and AxoPatch 200 amplifiers (Axon Instru-
ments), using borosilicate glass pipettes (1.5 mm outer diameter,
0.86 inner diameter) pulled on a P-97 Puller (Sutter Instru-
ments). Pipette resistances ranged from 2.5 to 5 MV.F o r
voltage-clamp experiments, the internal solution consisted of (in
mM): K
+ -gluconate (125), NaCl (10), CaCl2 (1.0), MgCl2 (2.0),
1,2-bis (2-aminophenoxy) ethane-N,N,N,N-tetra-acetic acid
(BAPTA) (0.1), Hepes (10), GTP (0.3) Mg -ATP (2.0); pH
adjusted to 7.3 with KOH. All experiments were performed in
presence of TTX (1 mM).
Current-clamp recordings were made in the perforated-patch
configuration. Gramicidin was used as the pore-forming agent
and was added to the pipette solution at an approximate
concentration of 20 mg/ml. The tip of the pipette was filled with
gramicidin-free intracellular solution. The perforation process
was considered complete when the amplitude of the action
potentials was steady and .60 mV, and electrode resistance was
steady and ,50 MV. For experiments with intrapipette BAPTA
(10 mM) and GDP-b-S, current-clamp experiments were
performed in the whole-cell configuration. Current–voltage
relationships were obtained by applying 50 pA steps in both
depolarizing and hyperpolarizing direction (from 2500 to 500
pA, 600 ms).
Statistical analysis
Data were analyzed using pClampfit 9.2 (Molecular Device),
Origin 8.0 (Microcal) and Prism 5.0 (GraphPad). Numerical data
are presented as means 6 SEM. The evaluation of statistical
difference was performed with two-way ANOVA test and paired
parametric statistical test (Student’s paired t-test). Nonparametric
post hoc comparisons were also performed among groups using
Tukey test to identify significant differences. Alpha was set at 0.01.
The significance level was set at p,0.05.
Acutely dissociated neurons
Striatal slices (,450 mm) were incubated in Hepes-buffered
Hank’s balanced salt solution (HBSS), bubbled with 100% O2,a t
32uC. One slice was then incubated in HBSS media with 0.5 mg/
ml protease XIV. After repeated wash-out in HBSS, the tissue was
mechanically triturated with a graded series of fire-polished
Pasteur pipettes. The cell suspension was placed in a Petri dish
mounted on the stage of an inverted microscope (Nikon Diaphot,
Japan). Healthy cells were allowed to settle for about 10-15 min
[20,25].
Electrophysiology. Patch-clamp recordings were performed
in the whole-cell configuration from dissociated interneurons, by
using glass pipettes (WPI PG52165-4, Germany) pulled with a
Flaming-Brown puller (Sutter Instrument, Novato, CA, U.S.A.)
and fire-polished before use. Pipette resistance ranged from 3 to
8M V. The composition of the internal solution was (in mM): N-
methyl-d-glucamine (185); HEPES (40); EGTA (11); MgCl2 (4);
phosphocreatine (20); adenosine triphosphate, ATP (2 to 3);
guanosine triphosphate, GTP (0 to 0.2); leupeptin (0.2); pH 7.36,
280 mOsm/L. After obtaining the cell access, cells were bathed
in (mM): TEA-Cl (155); CsCl2 (5); HEPES (10); and BaCl2 (5) as
the charge carrier; pH 7.35; 300 mOsm/L. Control and drug
solutions were applied with a linear array of six gravity-fed
capillaries positioned 500–600 mm close to the patched neuron.
Recordings were made with an Axopatch 1D (Axon Instruments).
Electrode resistances in bath were ,3–6 MV. After formation of
aG V seal and subsequent cell rupture, series resistance was
compensated (75–85%) and constantly monitored. Data were
low-pass filtered (corner frequency, 5 KHz). For data acquisition
and analysis, pClamp 9.2 software (Axon Instruments) was used.
Total HVA Ca
2+ current was examined by utilizing ramp test
(from 270 mV to +40 mV) or test pulse protocols (either a single
step from 260 mV to +10 mV or incremental 10 mV steps from
270 mV to +40 mV). The different components of HVA Ca
2+
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by sequentially applying the selective channel blockers: nifedipine
(NIFE, 5 mM), v-Conotoxin GVIA (Ctx-GVIA, 1 mM), v-
agatoxin IVA (Atx-IVA, 20 nM), and v-Conotoxin MVIIC
(Ctx-MVIIC, 100 nM). The voltage dependence of activation
was determined from measurements of tail current amplitude,
which was expected to reflect the fraction of calcium channels
opened during the preceding depolarization.
Data analysis. Voltage-activated currents were leak
subtracted. Cells exhibiting leak currents .10 pA were not
included in the analysis. The stability of cell capacitance (Cm)
during the experiment was monitored using the automated
function of the Axopatch amplifier. Statistical analysis was
performed using Microcal Origin (OriginLab, Northampton,
MA, U.S.A.) or GraphPad Prism (GraphPad Software, San
Diego, CA, U.S.A.) software. T-test or Mann-Whitney test were
used for assessing statistical significance where appropriate.
Multiple groups were compared using one-way or two-way
ANOVA. The Tukey HSD test was used for post hoc
comparison of the ANOVA. Values were considered statistically
significant when p , 0.05 with a =0.001. Values given in the text
and figures are mean 6 SD of changes in the respective cell
populations.
Drug source
Nifedipine, v-conotoxin GVIA, v-conotoxin MVIIC, and v-
agatoxin IVA were from Tocris-Cookson, UK. All other
compounds used were purchased from Sigma-Aldrich, Italy.
Immunohistochemistry and imaging
Mice were deeply anesthetized (avertin, 0.002 ml/0.01 kg) and
perfused through the aorta with ice-cold 4% paraformaldehyde.
The dissected brain were equilibrated with 30% sucrose
overnight. Thirty micrometer-thick coronal sections were cut
with a freezing microtome and dehydrated through a graded
ethanol series (50%–70%–50%). Slices were preincubated with
10% normal donkey serum solution (NDS) in PBS 0.25% Triton
X-100 (TPBS) for 1 h at room temperature (RT) and incubated
with the following primary antibodies at +4uC for three
overnights: rabbit polyclonal anti-torsinA antibody 1:600 (Ab-
Cam cod. ab34540) and goat anti-ChAT 1:300 (Novus biologicals
cod. NBP1-30052) in TPBS 1% NDS. After being washed with
TPBS, the sections were incubated with Alexa488-conjugated
donkey anti-rabbit (Invitrogen cod. A11008) and Cy3-conjugated
donkey anti-goat secondary antibodies (Jackson Immuno Re-
search cod. 705–165–147) 1:200 for 2 h at RT. Sections were
finally washed and mounted with VectashieldH mounting
medium on poly-L-lysine-coated slides, air-dried, and cover-
slipped. The specificity of the antibody was previously tested [11].
All images were acquired with Zeiss LSM 700 confocal laser
scanning microscope using the 40X/1.3 NA oil objective
(resolution pixel 102461024). We collected several optical section
images in the z-dimension (z-spacing, 1 mm) to fully capture the
cholinergic interneurons. The confocal pinhole was kept at 1, the
gain and offset setting were set to prevent saturation of the
brightest signals, and sequential scanning for each channel was
performed. To test for the specificity of the antisera, primary
antibodies were substituted with normal serum and, accordingly,
the immunolabeling was absent. Moreover, the specificity of
torsinA antibody was already tested by western blot on striatum
extracts (Napolitano et al., 2010). Images (five for each group and
age) were acquired from serial coronal sections in the dorsal
striatum of adult and P14 NT and hMT mice.
Results
Electrophysiological and morphological properties of
cholinergic interneurons
TorsinA protein expression is temporally and spatially regulated
in several regions of normal human and rodent brain [21,23,26–
29]. In particular, torsinA expression, measured as mRNA level, is
highest during prenatal and early postnatal development (until
postnatal day 14, P14), suggesting a role in the developing nervous
system [22,27,29]. Interestingly, among different neuronal popu-
lations, the striatal cholinergic interneurons seem to have a
prominent level of torsinA at P14 [22]. In the transgenic hMT1
mice, the mutant torsinA transcript is under the regulation of a
viral CMV promoter, and may have different spatial and temporal
patterns of expression. Therefore, we investigated the immuno-
histochemical localization of torsinA in cholinergic interneurons of
NT and hMT transgenic mice at this age. To this end, we
performed double immunofluorescence experiments by incubating
striatal coronal sections with specific antibodies against torsinA,
and against choline acetyltransferase (ChAT) to detect cholinergic
interneurons (Fig. 1). We observed a widespread and uniform
torsinA labeling of the striatum at P14 in both NT and hMT
(Fig. 1), as in the adult (data not shown; [6]). We did not observe
macroscopic alterations in the cellular localization of torsinA in the
hMT mice, which was confined to the cytoplasm and to proximal
dendrites of the cholinergic neurons (Fig. 1B–C and E–F).
Moreover, the cholinergic morphology defined by the ChAT-
staining looked similar in both experimental groups at P14
(Fig. 1A–B) and at 3 months (data not shown). These results
strengthen the observation that the pattern of torsinA distribution
in NT and hMT mice is similar in striatal neurons, as it is in the
striatum of normal and DYT1 mutation carriers [30].
Cholinergic interneurons, visualized with IR-DIC videomicro-
scopy, exhibited typical morphological features such as a large
polygonal cell body and two-three major aspiny dendritic branches
(Fig. 2A–A1). The electrophysiological properties of these neurons
confirmed the morphological identification. The recorded cells
had a depolarized resting membrane potential (RMP), a long-
lasting afterhyperpolarization (AHP) and a prominent Ih current
elicited by hyperpolarizing current steps (Fig. 2B–C). All these
properties have been unequivocally attributed to cholinergic
interneurons [31,32]. No significant difference of intrinsic
membrane properties, such as RMP (25664.5 mV and
26162.6 mV, at P14 and P90, respectively), input resistance
(11068.5 MV and 12865.8 MV, at P14 and P90), Ih current
(368611 pA and 318621 pA at P14 and P90) was recorded in
hMT mice between P14 and P90 (Fig. 2; n=23; p.0.05).
Similarly, such properties did not differ among the three strains of
mice (Table 1; p.0.05). In order to study the spontaneous firing
activity of cholinergic interneurons, current-clamp experiments
were performed in the perforated patch-clamp configuration,
preserving a more physiological intracellular ion concentration
with respect to the whole-cell configuration [33]. In such
condition, tonic rhythmic spiking activity was observed in nearly
all of the recorded neurons (,90%).
Spontaneous firing activity of cholinergic interneurons is
modulated by intrinsic membrane properties, but also by
activation of distinct neurotransmitter receptors [34]. To control
for non-specific effects of the torsinA overexpression, we
investigated the effect of muscarinic, GABAergic and metabotro-
pic glutamate receptor activation on the tonic activity of
cholinergic interneurons. First, we measured the response to
muscarinic M2/M4 autoreceptor activation at P14 and P90, which
produces a membrane hyperpolarization coupled to a transient
Dopamine-Acetylcholine Imbalance in DYT1 Dystonia
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animals, bath-application of the selective M2/M4 agonist oxo-
tremorine (300 nM, 3 min) caused a membrane hyperpolarization
and inhibited neuronal firing in hMT mice at both ages examined
(Fig. 3A,A1; P14: 2.360.81 mV; P90: 2.860.66 mV; p.0.05;
n=8 for each group). These data show that the muscarinic
autoreceptor function is preserved in mice with mutant torsinA at
both ages tested. No difference was measured among genotypes
(not shown; n= 8; p.0.05). Next, we analyzed the response of
cholinergic interneurons from hMT mice to baclofen, a GABAB
receptor agonist, which has been shown to inhibit cell firing [35].
Bath-applied baclofen (10 mM, 2 min) caused a reversible
membrane hyperpolarization coupled to blockade of firing activity
both in P14 (3.560.8 mV), as well as in P90 mice (2.860.5 mV,
n=8 for each group, p.0.05) (Fig. 3B,B1). The response to
baclofen was not significantly different among NT, hWT and
hMT neurons (not shown; n=8 for each group; p.0.05). Finally,
we examined the effect of dihydroxyphenylglycine (3,5-DHPG), a
group I metabotropic glutamate receptor agonist, which has a
robust excitatory effect on this cell type [36]. Bath-applied 3,5-
DHPG (10 mM, 30 s) induced a rapid and transient membrane
depolarization with a prominent increase in firing rate. The
response to 3,5-DHPG was not significantly different between
neurons recorded at P14 and P90 (Fig. 3C,C1; respectively from
0.560.27 to 7.3862.3 Hz; and from 0.6160.38 to 6.6861.88 Hz;
n=8 for each group, p.0.05). No difference was measured
among genotypes (not shown; n= 8; p.0.05).
Early alteration of D2R signalling in cholinergic
interneurons
In a previous report, we showed that application of the D2R
agonist quinpirole induces a paradoxical excitatory effect in striatal
cholinergic interneurons from 9-months-old hMT mice overex-
pressing human mutant torsinA [20]. In order to establish whether
developmental changes affect D2R signalling, we extended this
characterization to P14 and P90 hMT mice. The latter group is
comprehensive of recordings performed between P70 and P120.
Because no difference was observed, data were pooled together.
Bath-application of quinpirole (10 mM, 2 min) had no
significant effect on membrane potential or input resistance of
interneurons recorded from NT and hWT mice at both ages
examined, though a slight, but not significant decrease in firing
discharge was observed (n=8; p.0.05; Fig. S1A). Conversely, in
hMT mice recorded at both P14 and P90, quinpirole depolarized
the recorded cells and significantly increased the rate of action
potential discharge (Fig. 4A.B; P14: from 1.660.35 to
2.760.25 Hz; P90: from 1.760.20 to 2.960.15 Hz, n=10 for
each group, p,0.05). Interspike interval (ISI) exhibits a clear left-
shift of the histogram, confirming the rise in firing rate. In fact,
after application of quinpirole, the number of action potentials
within a short time interval increased (Fig. 4A1,B1). Pre-treatment
with the D2R antagonist sulpiride (3 mM) fully prevented the
response to quinpirole at both ages (Fig. 4E), confirming the
selective activation of D2Rs. In principle, quinpirole can activate
both D2Rs and D3Rs proteins. However, the dorsal striatum lacks
D3Rs, and therefore the effects of quinpirole in this region are
ascribed to D2Rs [37,38].
Because developmental changes of both striatal cholinergic
innervation as well as of torsinA expression occur during an early
postnatal period [29,39], we extended our electrophysiological
analysis to two further ages: P10 and P20, in order to provide a
more complete developmental profile. Consistently with data
collected at P14 and P90, in interneurons recorded from hMT at
P10 and P20, bath application of quinpirole (10 mM, 2 min)
Figure 1. Immunohistochemical localization of torsinA in the cholinergic interneurons of NT and hMT mouse striatum.
Representative confocal images (z-series projections) obtained from coronal slices of NT and hMT mice immunolabelled for ChAT (green, A, D). The
macroscopic morphology of ChAT-positive cholinergic interneurons is apparently the same in the two groups at P14. Representative confocal images
(single sections) showing the immunostaining of torsinA (red, B and E) in the ChAT-positive cholinergic neurons (merge, C and F) of NT (B–C) and hMT
(E–F) mice. The cellular distribution of torsinA is similar between the groups. Scale bars: 10 mm.
doi:10.1371/journal.pone.0024261.g001
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potential discharge (Fig. 4C,D,E; P10: from 1.5960.15 to
2.360.17 Hz; P20: from 1.5360.33 to 2.3060.35 Hz, n=4 for
each group, p,0.05). Moreover, in hMT mice D2R activation led
to a significant change in the threshold for action potential
discharge (APth) at both ages, consistent with an increase in cell
excitability (Fig. 4D: P14: from 257.361.4 to 251.5061.06; P90:
from 255.3061.22 to 249.4060.8; P,0.005; n=10 for both
groups; p,0.05). Finally, in voltage-clamp experiments, bath
application of quinpirole (10 mM, 2 min) induced a long-lasting
inward current (I quinp) in hMT mice at both ages tested (Fig. 4E:
P14: 18.3361.4 pA; P90: 20.6760.88; n=8 for each age;
p,0.05). No significant change was observed between the two
different ages (p.0.05). Examination of the changes in membrane
conductance using hyperpolarizing voltage step (10 mV, 600 ms)
elicited before and during quinpirole application, revealed that I
quinp was associated with a significant increase in membrane
conductance in hMT mice at P14 and P90 (Fig. 4H; P14: at rest
4.2060.38 nS, in quinpirole 5.2760.15 nS; P90: at rest
4.5760.47 nS, in quinpirole 5.3060.16 nS; n=6 p,0.05).
During rhythmic spontaneous firing activity of cholinergic
interneurons, individual action potentials are followed by a brief
calcium-mediated current responsible for membrane hyperpolar-
ization, termed medium afterhyperpolarization (mAHP) [40]. In
hMT mice at both ages, D2R activation induced an evident
reduction of this AHP (Fig. 4A1–B2). To better explore this effect,
we performed current-clamp experiments using brief, small
current pulses (50 pA, 500 ms), able to induce a series of action
potentials (Fig. 5A). Then, we measured the mAHP evoked after
each individual spike before and after application of quinpirole. In
hMT mice, D2R activation clearly reduced the mAHP (Fig. 5A
right;7 8 62.7% of control; n=8; p,0.05), whereas it failed to
affect mAHP currents in hWT or NT mice (Fig. 5A left; NT:
9463,5%; hWT: 96.865.5% of control, p.0.05). These results
are consistent with the changes in action potential threshold, and
indicate that during the abnormal D2R-activation, the smaller
hyperpolarization enables a more rapid membrane repolarization,
allowing the cells to fire at higher rate.
Finally, we tested the effect of D2R activation on Ih current,
which participates in the modulation of firing activity [41]. In
hMT mice, bath-applied quinpirole induced an inhibitory effect
on the Ih current similar to that observed in interneurons from NT
and hWT mice (Fig. 5B expressed as % of control, NT:
72.1623.5; hWT: 70.465.0; hMT: 70.6064.5; n=6 for each
group; p.0.05), thereby ruling out a major involvement of Ih
current in the abnormal D2R-mediated response.
Gi/Go proteins involvement in D2R-mediated response of
hMT mice
D2R signalling is mediated through activation of Gi/Go
proteins, which are coupled to inhibition of adenylyl cyclase and
ion channel modulation [19,42]. To investigate whether the D2R-
dependent signalling mechanisms were altered in hMT mice,
recording pipettes were loaded with GDP-b-S (500 nM). The non-
hydrolysable GDP-b-S competes with endogenous GTP for the
nucleotide binding on G-proteins, locking G-proteins in an
inactive state. In whole-cell current-clamp experiments, intracel-
lular replacement with GDP-b-S fully prevented the response to
quinpirole, which failed to alter RMP or to induce significant
increase of firing rate in hMT (Fig. 6A) as well as hWT mice (Fig.
S1B). Accordingly, recordings from dissociated striatal cholinergic
interneurons showed that GDP-b-S was able to prevent, in hMT
mice as well as in NT and hWT animals, the inhibitory action of
quinpirole (10 mM) on HVA calcium currents (Fig. 6B; n=13;
p.0.05). In addition, the inhibitory effect of quinpirole on calcium
currents was blocked by pre-application of N-ethylmaleimide
(NEM, 50 mM Fig. 6C), a sulfhydryl alkylating agent, which
inhibits G-proteins [19]. Taken together, these results suggest that
the aberrant D2R response involves the coupling to their cognate
G-proteins.
Figure 2. Basic electrophysiological properties of striatal
cholinergic interneurons. Differential interference contrast images
showing the morphological properties of striatal cholinergic interneu-
rons in a slice preparation (A) and after enzymatic tissue dissociation
(A1). Note the large, polygonal soma. B, B1. Representative traces
showing voltage responses to current steps (100 pA, 600 ms) in both
depolarizing and hyperpolarizing direction in cholinergic interneurons
of hMT recorded at P14 and P90. Note the prominent Ih current evoked
by hyperpolarizing step (white arrow) and the robust AHP current
following the step ending (black arrow). A single representative action
potential is shown at higher sweep speed. C. I-V relationship (10 mV
step, 600 ms) recorded in the voltage-clamp mode confirm that no
significant difference in membrane properties were detected between
hMT and hWT mice.
doi:10.1371/journal.pone.0024261.g002
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hMT mice
D2R activation has been shown to inhibit calcium currents in
this neuronal subtype [19]. In a set of experiments, we recorded
calcium currents from acutely dissociated cholinergic interneurons
to test the inhibitory action of quinpirole. In hMT mice at P90, the
quinpirole-mediated inhibition on HVA current was significantly
increased, as compared to NT and hWT mice (Fig. 7A; NT:
29.3963.72%; hWT: 28.464.8%, hMT: 42.5465.9%; n=12 for
each group; p,0.05). To investigate in detail the composition of
the total HVA current in mutant mice, we performed a further set
of experiments by sequentially applying selective calcium channel
blockers in order to isolate each fraction. Application of nifedipine
(NIFE, 5 mM, L-type calcium channel blocker), Ctx-MVIIC
(100 nM, Q-type blocker) and Atx-IVA (20 nM, P-type blocker)
produced a comparable effect in all the examined groups (Fig. 7A1;
Table 1. Intrinsic membrane properties of cholinergic interneurons in NT, hWT and hMT mice.
NT hWT hMT
RMP (mV) IR (MU ` )
Ih
(pA) RMP (mV)
IR
(MU ` )
Ih
(pA) RMP (mV)
IR
(MU ` )
Ih
(pA)
P14 258641 3 2 683 7 4 612 256631 3 4 663 6 1 615 256661 1 0 683 6 8 611
P90 260621 4 2 693 3 8 624 259651 6 1 693 8 0 68 261631 2 8 683 1 8 621
doi:10.1371/journal.pone.0024261.t001
Figure 3. Cholinergic interneurons exhibit normal response to M2/M4, GABAB and group I mGlu receptor activation. Representative
traces of cholinergic interneurons recorded in the perforated patch-clamp configuration. Recordings were collected from hMT mice at P14 (left) and
P90 (right). A–A1. M2/M4 receptor activation by oxotremorine (300 nM, 3 min) induced a transient firing cessation with a membrane
hyperpolarization. No significant differences were measured at both ages. B–B1. Similarly, application of Baclofen, a GABAB receptor agonist
(10 mM, 2 min) reversibly blocked firing activity in hMT mice. C–C1. Activation of group I mGlu receptors by 3,5-DHPG (10 mM, 30 sec) induced a
prominent membrane depolarization coupled with a transient increase of firing rate.
doi:10.1371/journal.pone.0024261.g003
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PLoS ONE | www.plosone.org 6 September 2011 | Volume 6 | Issue 9 | e24261Figure 4. Early abnormal responsiveness to D2R stimulation in hMT mice. A–D. In hMT mice, quinpirole (10 mM, 2 min) caused a paradoxical
membrane depolarization coupled to a large increase in the rate of action potentials in cholinergic interneurons recorded from mice at four different
developmental ages. A1–D1. Sample traces show, at higher sweep speed, the firing rate measured before and at the peak of the effect of quinpirole
application. Note the reduction of mAHP in quinpirole (white and black arrows). Left-shift of the ISI plot (inset) confirm the increased firing frequency
induced by quinpirole at all tested ages. E. Graph plots summarize the effect of quinpirole at P10, P14, P20 and P90. The D2R antagonist sulpiride
(3 mM) prevented the aberrant response to quinpirole. F. Zoom of action potential recorded in control conditions (black trace) and in the presence of
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Cav2.2/N-type blocker) inhibited a greater portion of total
calcium current than in NT and hWT mice (Fig. 7A1; NT:
32.1365.9%; hWT: 29.1266.01%, hMT: 45.1365.2%; n=12;
p,0.05). To investigate whether the altered contribution of
Cav2.2/N-type fraction to total HVA current was involved in the
aberrant D2R-mediated response of cholinergic interneurons, we
performed occlusion experiments with each calcium channel
blockers. Only Ctx-GVIA prevented the inhibitory effect of
quinpirole (Fig. 7A2; quinpirole in Ctx-GVIA 102.3612.4% of
control; n=8; p.0.05), demonstrating that the increased
inhibitory effect of quinpirole on total HVA calcium current
observed in hMT mice is entirely mediated by an increased
contribution of Cav2.2/N-type channel fraction.
To further confirm these observations, a parallel set of voltage-
clamp experiments was performed in slice preparations. Voltage-
dependent currents were evoked by a series of depolarizing steps
from an holding potential of 260 mV. Bath-application of
quinpirole (10 mM) induced a transient current at depolarizing
holding potentials in hMT mice (Fig. 7Ba). D2R activation, in fact,
reduced the transient current evoked by a depolarizing step from
260 to +10 mV (Fig. 7Ba). To test whether the quinpirole effect
was mediated by HVA calcium channels, the non-specific blocker
cadmium (CdCl2, 300 nM) was applied to the perfusing solution.
CdCl2 fully occluded the effect of quinpirole (Fig. 7Bb). Further-
more, as observed in the recordings from isolated cells, pre-
incubation with Ctx-GVIA (1 mM) also prevented the effect of
quinpirole on step-evoked whole-cell current (Fig. 7Bc), further
supporting the hypothesis that the D2R action is mediated by
Cav2.2/N-type channels.
Finally, the role of calcium ion was confirmed by loading the
recording pipette recording with high concentration of the calcium
chelator BAPTA (10 mM). In such experimental condition, in
slices from hMT mice, quinpirole failed to induce the abnormal
D2R-evoked current (Fig. 7C, n=6, p.0.05).
D2R-Adenosine A2A receptor interaction
Biochemical and electrophysiological data demonstrate that
adenosine A2A receptors (A2ARs) are co-localized on the same
striatal medium spiny projection neurons expressing D2Rs, where
they counteract the activity of this latter class of receptors [11,43].
More recently, a co-localization of A2ARs and D2Rs was
demonstrated also in cholinergic interneurons [44]. This evidence
prompted us to test if the defective D2R function could be
overcome by blocking A2ARs. Pretreatment of striatal slices with
the selective A2AR antagonist SCH58621 (50 nM, 15 min) did
quinpirole (red trace) at P14 and P90. Note the decrease of AP threshold induced by D2R activation. Graphs summarize the changes at both ages. G.
Voltage-clamp recordings (holding potential 260 mV) showing that bath-application of quinpirole induces an inward current in hMT mice at P14 and
P90. H. Time-course of quinpirole effect on the membrane conductance at P14 and P90. D2R activation induced a significant increase in membrane
conductance at both ages.
doi:10.1371/journal.pone.0024261.g004
Figure 5. Ih and mAHP current modulation by D2R activation. A. Representative traces of mAHP recorded after a brief depolarizing current
pulse (50 pA, 500 ms) in hWT and hMT mice. Note that in hMT mice, quinpirole application (gray trace) significantly reduced mAHP. Summary graph
of D2R-mediated effects on mAHP in the three genotypes. B. Hyperpolarizing voltage steps (30 mV, 800 ms) in the presence of TTX (1 mM) were
delivered to induce an Ih current. Representative traces recorded in whole-cell configuration before (black) and after (red) quinpirole application in
hWT and hMT mice. Graph plot summarizes the effect of D2R activation on the Ih current in the three groups of mice.
doi:10.1371/journal.pone.0024261.g005
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the presence of SCH58621 in the bathing solution, the excitatory
effect of quinpirole (10 mM, 2 min) persisted unchanged, suggest-
ing that the functional coupling of A2ARs and D2Rs is lost in this
neuronal subtype in hMT mice (data not shown, n=6, p.0.05).
Discussion
Onset of DYT1 dystonia occurs typically between childhood
and early adolescence, an observation consistent with the notion
that it may be viewed as a neurodevelopmental disorder [2,7,9–
10]. A peculiar feature of this inherited form of dystonia is
represented by the reduced penetrance (,30%), but it remains
unclear what triggers dystonic symptoms in gene mutation
carriers. If carriers do not show symptoms prior to 26 years of
age, they usually remain unaffected. However, it is now well-
established that non-manifesting gene carriers have endopheno-
types even without overt dystonia, expanding the notion of
penetrance and phenotype [45]. To this respect, the lack of clear-
cut neurodegenerative alterations in post-mortem brain samples
from DYT1 patients [46] highlights the relevance of an underlying
network distortion [2,6,7]. In the present work, we demonstrate
that the physiological balance between DA and ACh is disrupted
as early as at P10 in mice with the DYT1 mutation and persists
along different developmental stages, without gross morphological
changes. This study represents the first systematic electrophysio-
logical and morphological characterization of the DA/ACh
interplay along development performed in an animal model of
DYT1 dystonia.
Cholinergic interneurons are autonomous pacemakers, and
their spiking activity, and consequently ACh release, are under the
inhibitory control of both muscarinic M2/M4 autoreceptors and
D2Rs [14,16–19]. Here, we show that in mice with the DYT1
mutation, the M2/M4 muscarinic response is preserved, whereas
Figure 6. Gi/Go protein involvement in D2R-mediated response. A. Representative traces of a hMT interneuron recorded in whole-cell
current-clamp configuration. In the presence of GDP-b-S in the recording pipette, the response to quinpirole was fully prevented. The graph shows
that the instantaneous firing frequency did not change after bath application of quinpirole (10 mM, 2–4 min). B. Data were collected from acutely
isolated interneurons of hMT mice. Pipette loading with GDP-b-S was able to block the inhibitory effect of quinpirole onto HVA calcium currents.
C. Application of quinpirole (10 mM 2–4 min) produced a robust inhibition of the total HVA calcium currents evoked by voltage-ramp protocols. Time-
course of drug application show that the pre-application of N-ethylmaleimide (NEM) fully occluded the inhibitory effect mediated by D2Rs activation.
Blue circles represent the HVA currents recorded in control condition. Red circles report the inhibitory effect of quinpirole.
doi:10.1371/journal.pone.0024261.g006
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PLoS ONE | www.plosone.org 9 September 2011 | Volume 6 | Issue 9 | e24261Figure 7. Calcium ion involvement in D2R-mediated response. A–A2. Data collected from acutely isolated neurons. A. Graph plot summarizes
the inhibitory effect of quinpirole application on HVA calcium current evoked by voltage-ramp protocols. A1. Bar graph shows an increased Cav2.2/N-
type fraction of total HVA current in isolated interneurons of hMT mice. A2. Time-course of the peak calcium current before and after drug
application. The inhibitory effect produced by quinpirole was occluded by pre-application of v-conotoxin GVIA. B. Data collected from brain slices.
Representative traces of voltage dependent currents evoked by a series of depolarizing steps from an holding potential of 260 mV. Currents were
evoked in the presence of TTX (1 mM) in order to eliminate Nav channel-mediated inward currents in the sub- and supra-threshold voltage range.
Application of the D2R agonist quinpirole (10 mM, a) clearly reduces the outward current evoked by depolarizing steps. Slices pre-incubation with
CdCl2 (300 nM) almost fully abolished the quinpirole-mediated effect (b). Blockade of Cav2.2/N-type calcium channels by v-conotoxin GVIA (1 mM, c)
largely reduced the quinpirole effect on step-evoked current. Graphs report the normalized current recorded for each voltage level. C. Representative
traces of cholinergic interneurons recorded in whole-cell current clamp experiments in hMT mice. Intracellular replacement with an high BAPTA
concentration (10 mM) fully prevented the abnormal response after quinpirole application. C1. Plot of instantaneous firing frequency confirm that no
significant increase of firing rate was caused by D2R activation in the presence of BAPTA.
doi:10.1371/journal.pone.0024261.g007
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excitation throughout different developmental stages.
Dysfunction of the striatal dopaminergic system in dystonia has
been documented in a number of clinical and experimental settings
[8,9,47–51]. Indeed, numerous imaging studies have identified
D2R alterations in patients with primary dystonia [47,52,53].
Recently, Carbon and co-workers demonstrated a significant
reduction of D2R availability in the caudate and putamen of both
manifesting and non-manifesting DYT1 mutation carriers [9],
postulating that these alterations might represent an endophenotype
or a susceptibility factor for developing dystonia. Alterations in DA
neurotransmission is evident also inmodels of DYT1 dystonia.Mice
overexpressing mutant torsinA display an increased DA turnover
[49], and an altered DA transporter function [54]. In addition, in
striatal spiny projection neurons, a D2R dysfunction has been
demonstrated, with reduced abundance of D2R protein and
impaired capacity of D2Rs to activate their cognate Go/i proteins
[11]. Nonetheless, it remains still to be addressed whether these
alterations represent compensatory changes or if they may be
considered pathogenic features of the disease.
Cholinergic interneurons express D2Rs [55] and our results
with sulpiride confirm a receptor-specific alteration in D2R-
mediated responses. These observations point directly to a
decreased D2R function, although the molecular link between
mutated torsinA and D2R dysfunction has not been identified yet
[10]. Most of the effects exerted by D2Rs are mediated via
activation of Gi/Go proteins, which are coupled to inhibition of
adenylyl cyclase and modulation of ion channels [42,56]. Our data
show that the D2Rs retain their ability to activate G proteins in
cholinergic interneurons. Indeed, intracellular application of the G
protein inhibitor GDP-b-S, as well as bath-perfusion of the
alkylating agent NEM, completely prevented the abnormal
response to quinpirole. However, mutant mice display lower
levels of striatal RGS9 [11]. This protein acts as GTPase-
accelerating protein, thereby promoting G protein inactivation.
One possible interpretation is that reduced RGS9 expression
represents an adaptive response to compensate for reduced D2R
functioning. Nonetheless, it is also plausible that decreased activity
of RGS9 would enable a persistent coupling to D2R, prolonging
its activation in a non-physiological manner.
This assumption finds support in our data on HVA calcium
currents. D2R activation is coupled to inhibition of Cav2.2/N-
type channels in a membrane-delimited, PKC-insensitive manner
[19]. In cholinergic interneurons from hMT mice, the sensitivity to
quinpirole-mediated inhibition of the total calcium evoked
currents (HVA) was strikingly increased. Accordingly, these
changes were accompanied by an enhanced representation of
Cav2.2/N-type current fraction. Moreover, the D2R mediated
response was fully prevented by blocking Cav2.2/N-type channels.
Together with previous evidence demonstrating such alterations in
9-months-old mice [20], our current data testify the occurrence of
these changes at early developmental stages. These data are even
more intriguing considering that the D2R-dependent modulation
of Cav2.2/N-type channels normally exhibits an age-dependent
decrease in cholinergic interneurons. In fact, D2R-mediated
inhibition decreases in parallel with the reduction in Cav2.2/N-
type channel contribution to total current fraction [57,58].
The functional increase of the Cav2.2 -mediated current
fraction would be expected to enhance the inhibitory effect of
quinpirole on cholinergic interneurons. Then, what drives the
inhibition into a paradoxical excitation? A plausible explanation
resides in the complex regulation of the pacemaking activity of
these interneurons. Calcium currents are selectively coupled to
calcium-dependent potassium conductances underlying the after-
hyperpolarization (AHP) which follows single action potential [40].
In hMT mice, the membrane depolarization coupled to the
increase in firing discharge induced by quinpirole was accompa-
nied by a reduction in the mAHP amplitude, thereby moving cell
membrane potential closer to firing threshold. Consistently,
chelation of intracellular calcium by injecting BAPTA through
the recording pipette completely abolished the effect of quinpirole,
further suggesting that activation of calcium-dependent potassium
conductances plays a role in the altered D2R-mediated response.
Our findings do not exclude the possibility that other
neurotransmitter systems may be affected by mutant torsinA in
other models and in humans. However, the normal responses to
metabotropic glutamate receptor activation, together with the
normal muscarinic autoreceptor and GABAB responses described
in the present study seem to rule out a major role of other
neurotransmitters.
Abnormal D2R signaling has been shown to have relevant
functional consequences on striatal circuitry, by elevating the levels
of ambient ACh. The increased cholinergic tone, proven by an
enhancement of AChE activity and consistent with an enhanced
turnover of ACh, was indeed responsible for the loss of
corticostriatal long term depression and synaptic depotentiation in
hMT mice [6]. These data are coherent with the clinical
observation that an effective therapy for dystonia is treatment with
anticholinergic drugs such as trihexyphenidyl, a preferred M1
muscarinic receptor antagonist [59,60], and strengthens the
hypothesis that the striatal DA/ACh imbalance has a relevant role
in the pathophysiology of dystonia. Although the molecular
mechanisms underlying torsinA dysfunction have not been fully
elucidated, mutant torsinA might induce a sensitization to
endoplasmic reticulum stressors. An abnormal protein trafficking
would have functional consequences on neurotransmission, as
changes in the levels of neurotransmitter transporters, receptors and
accessory proteins, with profound effects on synaptic activity [10].
To date, the absence of a clear link between electrophysiological
alterations and motor phenotype described in mice overexpressing
mutant torsinA DYT1 mouse model suggest caution in the
interpretation of our results. However, these data seem to suggest
that approaches aimed at normalizing striatal dopaminergic/
cholinergic balance may be a successful approach to developing
alternative treatments for DYT1 dystonia.
Supporting Information
Figure S1 Representative traces of cholinergic interneurons
recorded in perforated patch-clamp mode. A. In hWT mice bath-
application of quinpirole (10 mM 2-4 min) caused a small reduction
of firing rate activity. Time-course plot (inset) shows that quinpirole
induced a small reduction of instantaneous firing frequency. B. In
hWT animals, D2R activation did not produce any significant
effect on membrane potential or firing activity when GDP-b-S (10
mM) was added to the intracellular recording solution.
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